ELEV logo

Elevation Oncology (ELEV)

Profile

Full Name

Elevation Oncology, Inc.

Ticker Symbol

ELEV

Exchange

NASDAQ

Country

United States

IPO

June 25, 2021

Indexes

Not included

Employees

34

Key Details

Price

$0.39(+16.62%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.78(+37.60% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 24, 25 Stephens & Co.
Equal-Weight
Mar 21, 25 Piper Sandler
Neutral
Mar 21, 25 Leerink Partners
Market Perform
Mar 21, 25 HC Wainwright & Co.
Buy
Mar 21, 25 Citizens Capital Markets
Market Perform
Mar 10, 25 HC Wainwright & Co.
Buy
Mar 10, 25 Citizens Capital Markets
Market Outperform
Mar 7, 25 Stephens & Co.
Overweight
Jan 14, 25 HC Wainwright & Co.
Buy
Jan 3, 25 William Blair
Outperform

Institutional Ownership

  • What is the ticker symbol for Elevation Oncology?
  • Does Elevation Oncology pay dividends?
  • What sector is Elevation Oncology in?
  • What industry is Elevation Oncology in?
  • What country is Elevation Oncology based in?
  • When did Elevation Oncology go public?
  • Is Elevation Oncology in the S&P 500?
  • Is Elevation Oncology in the NASDAQ 100?
  • Is Elevation Oncology in the Dow Jones?
  • When was Elevation Oncology's last earnings report?
  • When does Elevation Oncology report earnings?
  • Should I buy Elevation Oncology stock now?

What is the ticker symbol for Elevation Oncology?

The ticker symbol for Elevation Oncology is NASDAQ:ELEV

Does Elevation Oncology pay dividends?

No, Elevation Oncology does not pay dividends

What sector is Elevation Oncology in?

Elevation Oncology is in the Healthcare sector

What industry is Elevation Oncology in?

Elevation Oncology is in the Biotechnology industry

What country is Elevation Oncology based in?

Elevation Oncology is headquartered in United States

When did Elevation Oncology go public?

Elevation Oncology's initial public offering (IPO) was on June 25, 2021

Is Elevation Oncology in the S&P 500?

No, Elevation Oncology is not included in the S&P 500 index

Is Elevation Oncology in the NASDAQ 100?

No, Elevation Oncology is not included in the NASDAQ 100 index

Is Elevation Oncology in the Dow Jones?

No, Elevation Oncology is not included in the Dow Jones index

When was Elevation Oncology's last earnings report?

Elevation Oncology's most recent earnings report was on Mar 6, 2025

When does Elevation Oncology report earnings?

The next expected earnings date for Elevation Oncology is May 2, 2025

Should I buy Elevation Oncology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page